These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11014226)

  • 1. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
    Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
    Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
    Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
    J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GIP(3-30)NH
    Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
    Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.
    Baggio L; Kieffer TJ; Drucker DJ
    Endocrinology; 2000 Oct; 141(10):3703-9. PubMed ID: 11014225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
    Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
    Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
    Lu SC; Chen M; Atangan L; Killion EA; Komorowski R; Cheng Y; Netirojjanakul C; Falsey JR; Stolina M; Dwyer D; Hale C; Stanislaus S; Hager T; Thomas VA; Harrold JM; Lloyd DJ; Véniant MM
    Cell Rep Med; 2021 May; 2(5):100263. PubMed ID: 34095876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
    Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
    Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists.
    Naylor J; Suckow AT; Seth A; Baker DJ; Sermadiras I; Ravn P; Howes R; Li J; Snaith MR; Coghlan MP; Hornigold DC
    Biochem J; 2016 Sep; 473(18):2881-91. PubMed ID: 27422784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human GIP(3-30)NH
    Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
    Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
    Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
    FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIP(3-30)NH
    Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
    Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
    Puddu A; Sanguineti R; Montecucco F; Viviani GL
    J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
    Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
    J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.